Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsChemotherapy, AdjuvantRadiation DosageRadiation, IonizingDoxorubicinRadiation InjuriesT-Lymphocytes, CytotoxicCisplatinCell Line, TumorNeoplasmsDrug Screening Assays, AntitumorCombined Modality TherapyDose-Response Relationship, RadiationRadiation ToleranceRadiationDrug Resistance, NeoplasmTreatment OutcomeEtoposideAntineoplastic Agents, PhytogenicApoptosisCyclophosphamideRadiation ProtectionBreast NeoplasmsCell SurvivalRadiation MonitoringAntibiotics, AntineoplasticPaclitaxelTumor Cells, CulturedLung NeoplasmsTime FactorsDisease-Free SurvivalDose-Response Relationship, DrugRadiotherapyNeoadjuvant TherapySurvival AnalysisNeoplasm StagingDrug Delivery SystemsVinblastineAntimetabolites, AntineoplasticCamptothecinPrognosisMethotrexateRadiation OncologyXenograft Model Antitumor AssaysDrug Administration ScheduleMice, NudeSurvival RateOrganoplatinum CompoundsAntineoplastic Agents, AlkylatingCarboplatinCell ProliferationRadiotherapy DosageDNA DamageBleomycinTaxoidsDrug CarriersGamma RaysDeoxycytidineCytotoxicity, ImmunologicAdenocarcinomaDrug SynergismInhibitory Concentration 50Radiation-Sensitizing AgentsNeoplasm Recurrence, LocalRadiation Injuries, ExperimentalP-GlycoproteinDrug Resistance, MultipleRadiation PneumonitisCosmic RadiationDaunorubicinBrain NeoplasmsOvarian NeoplasmsNeoplasms, Radiation-InducedAnthracyclinesRadiotherapy, AdjuvantCarcinoma, Non-Small-Cell LungClinical Trials as TopicEllipticinesMitoxantroneMolecular StructurePlatinumFollow-Up StudiesColonic NeoplasmsCell CycleMitomycinNeoplasm MetastasisCytarabineInduction ChemotherapyGene Expression Regulation, NeoplasticUltraviolet RaysDacarbazineBackground RadiationNeoplasms, ExperimentalIfosfamideAntibodies, MonoclonalMice, Inbred BALB CFlow CytometryNeoplasm TransplantationCarcinoma, Squamous Cell